🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 15 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/12/2018 6,89 7,10 6,70 6,84 -0,73% 5,81% 107.700
14/12/2018 6,61 6,96 6,61 6,89 +0,88% 5,30% 37.100
13/12/2018 7,04 7,09 6,82 6,83 -2,29% 3,84% 39.500
12/12/2018 6,76 7,14 6,76 6,99 +4,17% 5,62% 21.800
11/12/2018 7,13 7,45 6,70 6,71 -3,59% 10,52% 116.600
10/12/2018 6,61 7,00 6,61 6,96 +3,42% 5,90% 109.100
07/12/2018 6,56 7,20 6,56 6,73 -0,59% 9,76% 105.800
06/12/2018 6,61 7,01 6,56 6,77 +6,28% 6,73% 96.000
04/12/2018 6,58 6,64 6,18 6,37 +0,79% 6,99% 122.400
03/12/2018 6,78 6,78 6,22 6,32 -2,32% 8,26% 77.100
30/11/2018 6,64 6,86 6,32 6,47 -0,92% 8,13% 250.100
29/11/2018 6,44 6,78 6,26 6,53 +3,65% 8,07% 298.700
28/11/2018 6,42 6,45 5,49 6,30 -9,87% 14,91% 778.500
27/11/2018 7,07 7,37 6,99 6,99 -3,05% 5,30% 68.500
26/11/2018 7,33 7,44 7,07 7,21 -1,50% 5,05% 42.800
23/11/2018 7,15 7,37 7,10 7,32 +3,39% 3,78% 19.900
21/11/2018 7,42 7,58 7,08 7,08 -4,71% 6,74% 43.400
20/11/2018 7,85 7,94 7,42 7,43 -5,59% 6,62% 29.900
19/11/2018 8,68 9,19 7,87 7,87 -10,26% 15,21% 57.600
16/11/2018 8,39 9,05 8,32 8,77 +3,30% 8,70% 65.000
15/11/2018 8,08 9,36 8,08 8,49 +4,43% 15,84% 85.500
14/11/2018 8,50 8,50 7,84 8,13 -2,52% 7,76% 41.700
13/11/2018 9,31 9,79 7,95 8,34 -10,99% 19,76% 141.300
12/11/2018 9,70 10,15 9,15 9,37 -3,40% 10,31% 232.300
09/11/2018 9,20 9,85 9,02 9,70 +4,64% 9,02% 115.500
08/11/2018 8,79 9,40 8,66 9,27 +2,43% 8,42% 146.300
07/11/2018 8,53 9,13 8,15 9,05 +4,14% 11,55% 148.900
06/11/2018 7,94 8,92 7,94 8,69 +9,58% 12,30% 58.300
05/11/2018 8,10 8,10 7,87 7,93 -1,73% 2,84% 18.300
02/11/2018 8,08 8,72 7,70 8,07 +0,37% 12,62% 73.000